Aethlon Medical Stock Analysis
AEMD Stock | USD 0.86 0.05 5.49% |
Aethlon Medical is undervalued with Real Value of 1.55 and Target Price of 3.85. The main objective of Aethlon Medical stock analysis is to determine its intrinsic value, which is an estimate of what Aethlon Medical is worth, separate from its market price. There are two main types of Aethlon Medical's stock analysis: fundamental analysis and technical analysis.
The Aethlon Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aethlon Medical's ongoing operational relationships across important fundamental and technical indicators.
Aethlon |
Aethlon Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aethlon Medical recorded a loss per share of 3.16. The entity last dividend was issued on the 15th of October 2019. The firm had 1:10 split on the 5th of October 2023. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. For more info on Aethlon Medical please contact MD Fisher at 619 941 0360 or go to https://www.aethlonmedical.com.Aethlon Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aethlon Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aethlon Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aethlon Medical is way too risky over 90 days horizon | |
Aethlon Medical has some characteristics of a very speculative penny stock | |
Aethlon Medical appears to be risky and price may revert if volatility continues | |
Aethlon Medical has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (12.21 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
Aethlon Medical currently holds about 14.92 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
Aethlon Medical has a frail financial position based on the latest SEC disclosures | |
Latest headline from MacroaxisInsider: Disposition of 3289 shares by Gikakis Nicolas of Aethlon Medical at 0.86 subject to Rule 16b-3 |
Aethlon Medical Upcoming and Recent Events
12th of February 2024 Upcoming Quarterly Report | View | |
26th of June 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
26th of June 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of March 2023 Last Financial Announcement | View |
Aethlon Largest EPS Surprises
Earnings surprises can significantly impact Aethlon Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2021-11-09 | 2021-09-30 | -0.15 | -0.13 | 0.02 | 13 | ||
2023-06-28 | 2023-03-31 | -0.13 | -0.1 | 0.03 | 23 | ||
2022-11-14 | 2022-09-30 | -0.21 | -0.18 | 0.03 | 14 |
Aethlon Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Wells Fargo & Co | 2024-09-30 | 211 | Advisor Group Holdings, Inc. | 2024-09-30 | 149 | Bank Of America Corp | 2024-09-30 | 114 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 89.0 | Bartlett & Co Wealth Management Llc | 2024-09-30 | 26.0 | Truvestments Capital Llc | 2024-09-30 | 5.0 | Hanson Mcclain Inc | 2024-09-30 | 2.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Jane Street Group Llc | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 218.3 K | Geode Capital Management, Llc | 2024-09-30 | 98.4 K |
Aethlon Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.65 M.Aethlon Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.33) | (1.40) | |
Return On Capital Employed | (2.26) | (2.15) | |
Return On Assets | (1.33) | (1.40) | |
Return On Equity | (2.43) | (2.31) |
Management Efficiency
Aethlon Medical has return on total asset (ROA) of (0.5046) % which means that it has lost $0.5046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0538) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of January 8, 2025, Return On Tangible Assets is expected to decline to -1.4. The current year's Return On Capital Employed is expected to grow to -2.15. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 376.7 K, whereas Other Assets are forecasted to decline to 0.86.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.07 | 2.17 | |
Tangible Book Value Per Share | 2.06 | 2.17 | |
Enterprise Value Over EBITDA | 0.01 | 0.01 | |
Price Book Value Ratio | 0.68 | 0.71 | |
Enterprise Value Multiple | 0.01 | 0.01 | |
Price Fair Value | 0.68 | 0.71 | |
Enterprise Value | -177.7 K | -168.9 K |
Aethlon Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Technical Drivers
As of the 8th of January, Aethlon Medical shows the Risk Adjusted Performance of 0.1236, mean deviation of 5.81, and Downside Deviation of 8.73. Aethlon Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aethlon Medical treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Aethlon Medical is priced correctly, providing market reflects its regular price of 0.86 per share. Given that Aethlon Medical is a hitting penny stock territory we recommend to closely look at its total risk alpha.Aethlon Medical Price Movement Analysis
The output start index for this execution was five with a total number of output elements of fifty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aethlon Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aethlon Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Aethlon Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aethlon Medical Outstanding Bonds
Aethlon Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aethlon Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aethlon bonds can be classified according to their maturity, which is the date when Aethlon Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Aethlon Medical Predictive Daily Indicators
Aethlon Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aethlon Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Aethlon Medical Forecast Models
Aethlon Medical's time-series forecasting models are one of many Aethlon Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aethlon Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Aethlon Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Aethlon Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aethlon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aethlon Medical. By using and applying Aethlon Stock analysis, traders can create a robust methodology for identifying Aethlon entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (18.85) | (19.80) | |
Operating Profit Margin | (23.83) | (25.02) | |
Net Loss | (24.09) | (25.30) | |
Gross Profit Margin | 0.48 | 0.51 |
Current Aethlon Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aethlon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aethlon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
3.85 | Buy | 2 | Odds |
Most Aethlon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aethlon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aethlon Medical, talking to its executives and customers, or listening to Aethlon conference calls.
Aethlon Stock Analysis Indicators
Aethlon Medical stock analysis indicators help investors evaluate how Aethlon Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aethlon Medical shares will generate the highest return on investment. By understating and applying Aethlon Medical stock analysis, traders can identify Aethlon Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 14.6 M | |
Common Stock Shares Outstanding | 2.5 M | |
Total Stockholder Equity | 5.8 M | |
Property Plant And Equipment Net | 1.9 M | |
Cash And Short Term Investments | 5.4 M | |
Cash | 5.4 M | |
Accounts Payable | 777.9 K | |
Net Debt | -4.5 M | |
50 Day M A | 0.446 | |
Total Current Liabilities | 1.8 M | |
Other Operating Expenses | 12.6 M | |
Non Current Assets Total | 2.3 M | |
Forward Price Earnings | 0.2102 | |
Non Currrent Assets Other | 398.6 K | |
Stock Based Compensation | 1.2 M |
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |